Evidence map›Paper›PMID 32024104›Full record

ArticleBiomolecules2020

Hippocampal CCR5/RANTES Elevations in a Rodent Model of Post-Traumatic Stress Disorder: Maraviroc (a CCR5 Antagonist) Increases Corticosterone Levels and Enhances Fear Memory Consolidation.

José Joaquín Merino, Vilma Muñetón-Gomez, César Muñetón-Gómez, María Ángeles Pérez-Izquierdo, María Loscertales, Adolfo Toledano Gasca

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. The contributing role of CCR5 in dementia.Frontiers in neurology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Effects ofFrontiers in molecular neuroscience · 2022
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

José Joaquín MerinoDept. Pharmacology, Pharmacognosy and Botanics. Complutense University of Madrid (UCM)., 28040 Madrid, Spain.
Vilma Muñetón-GomezLa Salle Center, Faculty of Agriculture Sciences, Av. Carrera 7. # 179-03 (sede norte, Bogotá, Colombia.
César Muñetón-GómezLa Salle Center, Faculty of Agriculture Sciences, Av. Carrera 7. # 179-03 (sede norte, Bogotá, Colombia.
María Ángeles Pérez-IzquierdoPsychobiology Dept, UNED (Madrid), 28040, Madrid, Spain.
María LoscertalesHarvard Medical School, MGH, Massachussets General Hospital, 185 Cambridge St Boston MA 02114, Boston, USA.
Adolfo Toledano GascaCajal Institute (CSIC), 28.002 Madrid, Spain.
University of La Salle · COInstituto Cajal · ESMassachusetts General Hospital · USNational University of Distance Education · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundContextual fear conditioning (CFC) is a rodent model that induces a high and long-lasting level of conditioning associated with traumatic memory formation; this behavioral paradigm resembles many characteristics of posttraumatic stress disorder (PSTD). Chemokines (chemotactic cytokines) play a known role in neuronal migration and neurodegeneration but their role in cognition is not totally elucidated.

aimWe ascertain whether CCR5/RANTES beta chemokines (hippocampus/prefrontal cortex) could play a role in fear memory consolidation (CFC paradigm). We also evaluated whether chronic stress restraint (21 days of restraint, 6-h/day) could regulate levels of these beta chemokines in CFC-trained rats; fear memory retention was determined taking the level of freezing (context and tone) by the animals as an index of fear memory consolidation 24 h after CFC training session; these chemokines (CCR5/RANTES) and IL-6 levels were measured in the hippocampus and prefrontal cortex of chronically stressed rats, 24 h after CFC post-training, and compared with undisturbed CFC-trained rats (Experiment 1). In Experiment 2, rats received 1 mA of footshock during the CFC training session and fear memory consolidation was evaluated at 12 and 24 h after CFC training sessions. We evaluated whether RANTES levels could be differentially regulated at 12 and 24 h after CFC training; in Experiment 3, maraviroc was administered to rats (i.m: 100 mg/Kg, a CCR5 antagonist) before CFC training. These rats were not subjected to chronic stress restraint. We evaluated whether CCR5 blockade before CFC training could increase corticosterone, RANTES, or IL-6 levels and affects fear memory consolidation in the rats 24-h post-testing compared with vehicle CFC-trained rats.

resultsElevations of CCR5/RANTES chemokine levels in the hippocampus could have contributed to fear memory consolidation (24 h post-training) and chronic stress restraint did not affect these chemokines in the hippocampus; there were no significant differences in CCR5/RANTES levels between stressed and control rats in the prefrontal cortex (Experiment 1). In Experiment 2, hippocampal CCR5/RANTES levels increased and enhanced fear memory consolidation was observed 12 and 24 h after CFC training sessions with 1 mA of footshock. Increased corticosterone and CCR5/RANTES levels, as well as a higher freezing percentage to the context, were found at 24 h CFC post-testing in maraviroc-treated rats as compared to vehicle-treated animals (experiment-3). Conversely, IL-6 is not affected by maraviroc treatment in CFC training.

conclusionOur findings suggest a role for a hippocampal CCR5/RANTES axis in contextual fear memory consolidation; in fact, RANTES levels increased at 12 and 24 h after CFC training. When CCR5 was blocked by maraviroc before CFC training, RANTES (hippocampus), corticosterone levels, and fear memory consolidation were greater than in vehicle CFC-trained rats 24 h after the CFC session.

Indexed as

Memory ConsolidationAdrenal Cortex HormonesAnimalsCCR5 Receptor AntagonistsChemokine CCL5CorticosteroneDisease Models, AnimalFearHippocampusImmunomodulationInterleukin-6MaleMaravirocMemoryNeuronal PlasticityPrefrontal CortexAdrenal Cortex HormonesCCR5 Receptor AntagonistsChemokine CCL5CorticosteroneIl6 protein, ratInterleukin-6MaravirocReceptors, CCR5CCR5/RANTES chemokineschronic stress restraintfear learningneural plasticityneuroimmunomodulation.neuroinmunologyneuro repairpost traumatic stress disorder

Identifiers

PMID32024104
PMCPMC7072246
OpenAlexW3003807880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.